Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H A Capell

Showing results (31-40 of 162) with videos related to

Pageof 17
Sort By:
International Journal of Clinical Practice|June 13, 2003
Etoricoxib in the treatment of chronic painM R Duncan, H A Capell
Bailliere'S Clinical Rheumatology|April 1, 1987
Drug treatment of pain in rheumatoid disordersH A Capell, S M Fraser
British Medical Journal (Clinical Research Ed.)|November 21, 1987
The natural course of gold nephropathyJ A Hunter, H A Capell
British Medical Journal (Clinical Research Ed.)|January 9, 1982
Unexplained acute arthritis in hemiplegiaW S Mitchell, H A Capell
Scottish Medical Journal|July 1, 1982
Does hypothyroidism predispose to gold-induced thrombocytopenia?J A Hunter, H A Capell
British Journal of Rheumatology|June 1, 1993
The 'natural' history of active rheumatoid arthritis over 3-6 months--an analysis of patients enrolled into trials of potential disease-modifying anti-rheumatic drugs, and treated with placeboD R Porter, H A Capell
Annals of Clinical Biochemistry|March 29, 2000
A patient with juvenile chronic arthritis and Henoch-Schönlein purpuraF C Ballantyne, H A Capell
Bailliere'S Clinical Rheumatology|December 1, 1990
The use of sulphasalazine as a disease modifying antirheumatic drugD R Porter, H A Capell
Rheumatology (Oxford, England)|July 2, 2003
Attitude of rheumatoid arthritis patients to treatment with oral corticosteroidsE Morrison, D Crosbie, H A Capell
Annals of the Rheumatic Diseases|September 1, 1986
A three year follow up of patients allocated to placebo, or oral or injectable gold therapy for rheumatoid arthritisH A Capell, D Lewis, J Carey
Pageof 17

Showing results (31-40 of 162) with videos related to

Sort By:
Pageof 17
International Journal of Clinical Practice|June 13, 2003
Etoricoxib in the treatment of chronic painM R Duncan, H A Capell
Bailliere'S Clinical Rheumatology|April 1, 1987
Drug treatment of pain in rheumatoid disordersH A Capell, S M Fraser
British Medical Journal (Clinical Research Ed.)|November 21, 1987
The natural course of gold nephropathyJ A Hunter, H A Capell
British Medical Journal (Clinical Research Ed.)|January 9, 1982
Unexplained acute arthritis in hemiplegiaW S Mitchell, H A Capell
Scottish Medical Journal|July 1, 1982
Does hypothyroidism predispose to gold-induced thrombocytopenia?J A Hunter, H A Capell
British Journal of Rheumatology|June 1, 1993
The 'natural' history of active rheumatoid arthritis over 3-6 months--an analysis of patients enrolled into trials of potential disease-modifying anti-rheumatic drugs, and treated with placeboD R Porter, H A Capell
Annals of Clinical Biochemistry|March 29, 2000
A patient with juvenile chronic arthritis and Henoch-Schönlein purpuraF C Ballantyne, H A Capell
Bailliere'S Clinical Rheumatology|December 1, 1990
The use of sulphasalazine as a disease modifying antirheumatic drugD R Porter, H A Capell
Rheumatology (Oxford, England)|July 2, 2003
Attitude of rheumatoid arthritis patients to treatment with oral corticosteroidsE Morrison, D Crosbie, H A Capell
Annals of the Rheumatic Diseases|September 1, 1986
A three year follow up of patients allocated to placebo, or oral or injectable gold therapy for rheumatoid arthritisH A Capell, D Lewis, J Carey
Pageof 17